View the BRATODX registration information details.
Back to drug list
ItemsDrug Registration information
ID201
No201
Brand NameBRATODX
IngredientsENCORAFENIB 75 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 42'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsIN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH A BRAF V600E OR V600K MUTATION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionRED-WHITE CAPSULE CONTAINS WHITE POWDER
Note
License OwnerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
ManufacturerBIGBEAR PHARMACEUTICAL LAO CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 L 1201/24
FDD Registration Date24/09/2024
Expiry Date23/09/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA